Delivery Order SPE2DB24D3014-SPE2DB25FKSRD

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $2,024.85 granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The delivery order has a firm fixed price and an ultimate completion date of May 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award, valued at $1,024.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,220.58 fixed-price delivery order covers the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 14, 2023 and was awarded on December 13, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,260.36 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription medication. The contract has an ultimate completion date of September 25, 2023 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,180.86 firm fixed-price delivery order covers the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin product. The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059.72 firm-fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of December 20, 2024 and does not utilize any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a firm fixed price of $1,497.60 and a period of performance through January 10, 2024. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,766.20 Firm Fixed Price Delivery Order contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,283.52 firm fixed-price delivery order covers the provision of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award is for $2,151.24 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of Humalog 100 Unit/mL KwikPen 3mL, a diabetes medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKSRD
    Delivery Order

This federal contract award, with ID SPE2DB24D3014|SPE2DB25FKSRD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,597.15, is a Firm Fixed Price Delivery Order for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML. There was no set-aside designation for this award.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/13/25, 10:00 AM